CLINICAL_TRIALS
trial_result
· 2016-04-12
Clinical Trial Update: A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease [Phase 3]
Summary
Phase 3 trial evaluating adalimumab after dose escalation in Japanese subjects with Crohn's disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-04-12